Efficacy and safety of activated charcoal in primary gout: A double-blind, double-dummy, randomized controlled trial
Authors:
Open Access
- 15 January 2026
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 139 (4) , 484-494.e1
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2022YFC250330)
- Key Technologies Research and Development Program
- National Natural Science Foundation of China (82301003)
- Natural Science Foundation of Shandong Province (ZR2023MH213)
This publication has 37 references indexed in Scilit:
- Risk of Venous Thromboembolism With Gout FlaresArthritis & Rheumatology, 2023
- Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quailBiomedicine & Pharmacotherapy, 2022
- Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With GoutJAMA, 2022
- Le Carbone prevents liver damage in non-alcoholic steatohepatitis-hepatocellular carcinoma mouse model via AMPKα-SIRT1 signaling pathway activationHeliyon, 2021
- Mathematical modeling analysis of hepatic uric acid disposition using human sandwich-cultured hepatocytesDrug Metabolism and Pharmacokinetics, 2020
- Brief Report: Validation of a Definition of Flare in Patients With Established GoutArthritis & Rheumatology, 2017
- 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative InitiativeArthritis & Rheumatology, 2015
- The effect of activated charcoal on adenine-induced chronic renal failure in ratsFood and Chemical Toxicology, 2014
- Developing a provisional definition of flare in patients with established goutArthritis & Rheumatism, 2011
- Role of the intestinal tract in the elimination of uric acidArthritis & Rheumatism, 1965